Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2012-005040-20Phase 4Completed
Phase 4, randomised trial of dextran in bladder cancer (2 arms), sponsored by Rigshospitalet. Primary endpoint: Coagulation competence. Started Jan 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2012-005040-20.